Explore

Trendline Trendline
Next Generation Sequencing Methods Proposed for Honey Authentication

Next Generation Sequencing Methods Proposed for Honey Authentication

Next Generation Sequencing Methods Proposed for Honey Authentication
Rapid Read Rapid Read
Research Highlights Role of G-Quadruplex Structures in Aging and Disease

Research Highlights Role of G-Quadruplex Structures in Aging and Disease

Recent studies have explored the impact of G-quadruplex structures on DNA replication stress, which is linked to aging and various genetic disorders. These structures, formed by guanine-rich DNA sequences, can impede DNA replication, leading to cellular senescence and genomic instability. The research highlights the role of G-quadruplexes as molecular switches that control gene expression and DNA replication. The findings suggest that replication stress, driven by these structures, contributes to aging and disease, including cancer. The study also discusses the potential therapeutic targets for overcoming replication stress and maintaining genomic stability.
Rapid Read Rapid Read
U.S. Researchers Develop DNA Encryption to Secure Engineered Cells Against Theft

U.S. Researchers Develop DNA Encryption to Secure Engineered Cells Against Theft

A team of U.S. researchers has introduced a novel approach to secure engineered cells using DNA encryption. This method involves scrambling the DNA of a cell, rendering its instructions non-functional until decrypted with a precise sequence of chemicals. The Centers for Disease Control and Prevention and the Department of Homeland Security have reported increased theft and smuggling of high-value biological materials, including engineered cells, which could be misused for bioweapons or environmental harm. Traditionally, these cells are protected by physical security measures, but the new genetic combination lock offers a more robust solution. The encryption process was tested through an ethical hacking exercise, achieving a 0.2% success rate in unauthorized access attempts, close to the theoretical target of 0.1%.
Trendline Trendline
Bruker Corporation Launches New NMR Products at ENC 2026

Bruker Corporation Launches New NMR Products at ENC 2026

Bruker Corporation Launches New NMR Products at ENC 2026
Rapid Read Rapid Read
U.S. Researchers Develop DNA Encryption to Secure Engineered Cells Against Unauthorized Access

U.S. Researchers Develop DNA Encryption to Secure Engineered Cells Against Unauthorized Access

A team of U.S. researchers has developed a novel DNA encryption method to protect engineered cells from unauthorized access. This approach involves scrambling the DNA of a cell, rendering its instructions non-functional until a precise sequence of chemicals is applied to unlock it. The method was tested through an ethical hacking exercise, where a 'red team' attempted to breach the system. Initially, they identified weak spots, but after improvements, the system's security was significantly enhanced, reducing the chance of unauthorized access to 0.2%. This development is particularly significant given the increasing theft and smuggling of high-value biological materials, which could be misused if they fall into the wrong hands.
Trendline Trendline
Bruker Corporation Launches Advanced NMR Products to Enhance Research Efficiency

Bruker Corporation Launches Advanced NMR Products to Enhance Research Efficiency

Bruker Corporation Launches Advanced NMR Products to Enhance Research Efficiency
Trendline Trendline
Experimental Drug Aims to Extend Lifespan of Senior Dogs

Experimental Drug Aims to Extend Lifespan of Senior Dogs

Experimental Drug Aims to Extend Lifespan of Senior Dogs
Rapid Read Rapid Read
Researchers Develop Injectable Hydrogel for Improved Surgical Sealant

Researchers Develop Injectable Hydrogel for Improved Surgical Sealant

A new injectable thixotropic hydrogel has been developed to address the issue of anastomotic leakage in gastrointestinal surgery. This hydrogel, composed of elastin-like polypeptide and oxidized dextran, offers a ready-to-use solution that solidifies upon contact with tissue, eliminating the need for intraoperative mixing required by conventional sealants like fibrin glue. The hydrogel demonstrates reversible sol-gel transitions and shear-responsive behavior, with the most oxidized formulation showing significant recovery of storage modulus after high strain. It exhibits adhesive strength and burst pressure comparable to fibrin glue, as demonstrated in lap-shear tests on porcine small intestine. In vivo experiments in mice showed the hydrogel's localization at the injection site for up to a week, with mild serosal thickening and no severe inflammation, indicating favorable physiological stability.
Rapid Read Rapid Read
BostonGene Showcases AI-Driven Drug Development at AACR Annual Meeting

BostonGene Showcases AI-Driven Drug Development at AACR Annual Meeting

BostonGene, a leader in AI-driven cancer research, is set to present 13 abstracts at the American Association for Cancer Research (AACR) Annual Meeting 2026. The company will demonstrate its AI foundation model for tumor and immune biology, which integrates genomic, transcriptomic, and spatial insights to accelerate drug discovery and optimize patient stratification. Key presentations include the use of AI-based tools for precision patient stratification, target identification, and prediction of drug-induced tissue dynamics. BostonGene's research highlights the potential of AI to transform the pharmaceutical pipeline by providing biologically grounded insights from early discovery through late-stage clinical trials.
Trendline Trendline
FairJourney Bio Opens Advanced Cryo-EM Facility in San Diego to Enhance Antibody Discovery

FairJourney Bio Opens Advanced Cryo-EM Facility in San Diego to Enhance Antibody Discovery

FairJourney Bio Opens Advanced Cryo-EM Facility in San Diego to Enhance Antibody Discovery
Trendline Trendline
Biotechnology and Pharmaceutical Services Outsourcing Market Projected to Reach USD 89.82 Billion by 2035

Biotechnology and Pharmaceutical Services Outsourcing Market Projected to Reach USD 89.82 Billion by 2035

Biotechnology and Pharmaceutical Services Outsourcing Market Projected to Reach USD 89.82 Billion by 2035
Trendline Trendline
Umbrella Labs Updates Documentation and Traceability for MSCs Exosomes in Research

Umbrella Labs Updates Documentation and Traceability for MSCs Exosomes in Research

Umbrella Labs Updates Documentation and Traceability for MSCs Exosomes in Research